TrialWorld journal of urology2017

Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.

Daimantas Milonas et al.PubMed ↗Publisher ↗

No numbers read from the abstract.